Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Shareholders' Equity for the year ending August 31, 2024: USD 65.18 M

Cannara Biotech Inc. Shareholders' Equity is USD 65.18 M for the year ending August 31, 2024, a 10.49% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Cannara Biotech Inc. Shareholders' Equity for the year ending August 31, 2023 was USD 58.99 M, a 16.14% change year over year.
  • Cannara Biotech Inc. Shareholders' Equity for the year ending August 31, 2022 was USD 50.80 M, a -0.05% change year over year.
  • Cannara Biotech Inc. Shareholders' Equity for the year ending August 31, 2021 was USD 50.82 M, a 72.89% change year over year.
  • Cannara Biotech Inc. Shareholders' Equity for the year ending August 31, 2020 was USD 29.40 M, a -16.68% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email